Yes abew, Dr. Missling and (growing) company continue to assert meeting both endpoints in our Alzheimer’s trial. Who would know better whether we met those or not than the newest edition(s) to the team. As cautious and conservative as Dr. Missling has been historically with attracting lawsuits he has either grown completely crazy, or he telling the truth. There is no way the new guys/gal would accept lead positions respectively on the BOD and VP if data were skewed/sketchy.
Many only see black and white through traditional “lenses” but the Anavex picture is coming quickly into color.
2023!
OAN, is it me or is Dr. Missling seem like he is shifting into 4rth gear comfortably cruising into approval. World wide market penetrations with most excellent patent protection, hiring, filing